神州细胞
(688520)
| 流通市值：154.58亿 | | | 总市值：163.25亿 |
| 流通股本：4.45亿 | | | 总股本：4.70亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 659,391,620.12 | 323,190,678.39 | 1,560,152,996.71 | 1,311,881,128.84 |
| 营业总成本 | 969,406,537.29 | 472,019,007.38 | 2,075,196,015.13 | 1,491,402,986.03 |
| 其他经营收益 | | | | |
| 营业利润 | -316,880,151.24 | -148,639,984.08 | -436,349,060.39 | -166,090,338.66 |
| 利润总额 | -378,934,889.85 | -181,575,945.8 | -563,621,357.37 | -251,279,601.67 |
| 净利润 | -377,200,763.09 | -181,283,974.94 | -566,202,185.71 | -251,279,601.67 |
| 每股收益 | | | | |
| 其他综合收益 | 90,405.65 | -772,094.69 | 134,911.37 | 92,768.44 |
| 综合收益总额 | -377,110,357.44 | -182,056,069.63 | -566,067,274.34 | -251,186,833.23 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,054,012,891.84 | 2,606,686,290.74 | 1,898,271,493.71 | 1,826,472,317.93 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,907,585,500.06 | 1,927,524,614.76 | 1,926,012,583.04 | 1,934,964,260.16 |
| 资产总计 | 3,961,598,391.9 | 4,534,210,905.5 | 3,824,284,076.75 | 3,761,436,578.09 |
| 流动负债: | | | | |
| 流动负债合计 | 2,345,318,821.49 | 2,659,404,614.42 | 2,735,093,427.2 | 2,994,131,066.29 |
| 非流动负债: | | | | |
| 非流动负债合计 | 976,052,780.53 | 1,040,670,042.68 | 968,859,364.14 | 822,080,022.29 |
| 负债合计 | 3,321,371,602.02 | 3,700,074,657.1 | 3,703,952,791.34 | 3,816,211,088.58 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 633,391,841.97 | 847,641,614.03 | 128,275,017.19 | -48,211,427.97 |
| 股东权益合计 | 640,226,789.88 | 834,136,248.4 | 120,331,285.41 | -54,774,510.49 |
| 负债和股东权益合计 | 3,961,598,391.9 | 4,534,210,905.5 | 3,824,284,076.75 | 3,761,436,578.09 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 766,574,740.71 | 379,044,901.65 | 1,906,375,251.92 | 1,367,147,362.09 |
| 经营活动现金流出小计 | 978,602,920.56 | 471,931,566.27 | 2,181,977,008.3 | 1,673,967,798.17 |
| 经营活动产生的现金流量净额 | -212,028,179.85 | -92,886,664.62 | -275,601,756.38 | -306,820,436.08 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,425,733,107.23 | 650,780,049.48 | 1,692,508,219.15 | 1,131,748,227.62 |
| 投资活动现金流出小计 | 1,699,534,002.84 | 786,733,460.81 | 1,984,488,409.5 | 1,480,076,700.06 |
| 投资活动产生的现金流量净额 | -273,800,895.61 | -135,953,411.33 | -291,980,190.35 | -348,328,472.44 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,556,445,236.53 | 1,110,437,829.42 | 2,951,519,740 | 1,836,155,437.14 |
| 筹资活动现金流出小计 | 1,071,200,506.99 | 227,298,396.67 | 1,928,482,166.01 | 1,099,382,708.29 |
| 筹资活动产生的现金流量净额 | 485,244,729.54 | 883,139,432.75 | 1,023,037,573.99 | 736,772,728.85 |
| 汇率变动对现金及现金等价物的影响 | -53,129.89 | 3,134.43 | -58,686.45 | -59,520.03 |
| 现金及现金等价物净增加额 | -637,475.81 | 654,302,491.23 | 455,396,940.81 | 81,564,300.3 |
| 期末现金及现金等价物余额 | 769,693,388.79 | 1,424,633,355.83 | 770,330,864.6 | 396,498,224.09 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -637,475.81 | - | 455,396,940.81 | - |